Search
for
Sort by
Research 811–840 of 1000+
- Anabolic effects of testosterone are preserved during inhibition of 5α-reductase
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Antiandrogens: Clinical applications
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- An Update on Plant Derived Anti-Androgens
- Recent advances in thiasteroids chemistry
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Androgen antagonists in androgen target tissues
- Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity
- Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
- Finasteride: The First 5α-Reductase Inhibitor
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Disease Versus Disease: How One Disease May Ameliorate Another
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- Therapeutic Androgen Receptor Ligands
- Does Finasteride Have a Preventive Effect on Chronic Bacterial Prostatitis? Pilot Study Using an Animal Model
- Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist
- Development of finasteride/PHBV@polyvinyl alcohol/chitosan reservoir-type microspheres as a potential embolic agent: from <i>in vitro</i> evaluation to animal study
- New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide)
- Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- 25 years of ERβ: a personal journey
- Economic Issues in the Treatment of BPH
- Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia